Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis is a topic covered in the Washington Manual of Medical Therapeutics.

To view the entire topic, please or purchase a subscription.

The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:

Washington Manual

-- The first section of this topic is shown below --

General Principles

PSC is a cholestatic liver disorder characterized by inflammation, fibrosis, and obliteration of the extrahepatic and/or intrahepatic bile ducts.

  • PSC can be subdivided into small duct and large duct disease. Small duct disease is defined as typical histologic features of PSC with a normal cholangiogram. In classic PSC, typical “beads on a string” strictures of the biliary tree can be detected by cholangiography. Small duct disease carries a more favorable prognosis.1
  • The peak incidence is at about age 40 years. Most patients are middle-aged men, and the male-to-female ratio is 2:1.
  • PSC is frequently associated with IBD (70% of patients have concomitant UC). The clinical course of these conditions is not correlated.
  • PSC increases the risk of colon cancer, in addition to the risk conferred by IBD alone.

-- To view the remaining sections of this topic, please or purchase a subscription --